Allergic bronchopulmonary aspergillosis in patients with asthma: dynamics of immunological parameters during antimycotic therapy


Cite item

Full Text

Abstract

Background. To determine the frequency of allergic bronchopulmonary aspergillosis in patients with asthma and to study the dynamics of immunological parameters in patients with allergic bronchopulmonary aspergillosis during antimycotic therapy. Methods. During investigation of 176 patients with asthma the group of patients with allergic bronchopulmonary aspergillosis was isolated. Allergological (skin tests with fungal allergens, serum total IgE, specific IgE to fungal allergens), immunological (IFN-γ, IL-10) and mycological (microscopy and culture of respiratory samples) examination was performed. Computer tomography of the chest was done when indicated. Results. In patients with asthma frequency of sensitization to Aspergillus spp. was 27%, with allergic bronchopulmonary aspergillosis - 4%. The increased activity of T-helper type 2 in patients with allergic bronchopulmonary aspergillosis (n=7) was revealed. After itraconazole treatment during 24 weeks serum total IgE reduced (p=0,04), spontaneous and induced production of IFN-γ ratio was normalized. The reduction of the absolute number of eosinophils in 4 (80%) patients, decreased production of sIgE to Aspergillus spp. in 3 (60%) patients were noted. Conclusion. All patients with severe asthma needed additional allergological and mycological examination for the detection of allergic bronchopulmonary aspergillosis. Itraconazole therapy was effective, reduced fungal burden, and resulted to restoring of Th2/Th1 imbalance in patients with allergic bronchopulmonary aspergillosis.

About the authors

Y I Kozlova

North-Western State Medical University named after I.I. Mechnikov

Email: kozlova510@mail.ru
St. Petersburg, Russia

A V Sobolev

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

E V Frolova

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

A E Uchevatkina

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

L V Filippova

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

O V Aak

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

O A Shurpitskaya

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

N N Klimko

North-Western State Medical University named after I.I. Mechnikov

St. Petersburg, Russia

References

  1. Knutsen A.P., Slavin R.G. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin. Dev. Immunol. 2011, p. 843-863. doi: 10.1155/2011/843763.
  2. Denning D.W., O’Driscoll B.R., Hogaboam C.M. et al. The link between fungi and asthma: A summary of the evidence. Eur. Respir. J. 2006, v. 27, p. 615-626.
  3. Agarwal R. Severe asthma with fungal sensitization. J. Fungi. 2016, v. 2, p. 13-18.
  4. Knutsen A.P., Bush R.K., Demain J.G. et al. Fungi and allergic lower respiratory tract diseases. J. Allergy Clin. Immunol. 2012, v. 129, p. 280-291.
  5. Козлова Я.И., Соболев А.В., Фролова Е.В., Аак О.В., Бурыгина Е.В., Климко H.H. Аллергический бронхолегочный аспергиллез у больных бронхиальной астмой. Росс. Аллергол. Журн. 2015, № 2, с. 37-46.
  6. Ashok Shah, Chandramani Paniabi. Allergie Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity. Allergy Asthma Immunol. Res. 2016, v. 8, p. 282-297.
  7. Chaudhary N., Datta K., Askin F.B. et al. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. J. Respir. Crit. Care Med. 2012, v. 185, p. 301-310.
  8. Denning D.W., Pashley C., Hartl D. et al. Fungal allergy in asthma-state of the art and research needs. Clinical and Translational Allergy. 2014, v. 4, p. 14.
  9. Hogan C., Denning D.W. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin. Respir. Crit. Care Med. 2011, v. 32, p. 682-692.
  10. Agarwal R., Aggarwal A.N., Gupta D., Jindal S.K. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: Systematic review and meta-analysis. Int. J. Tuberc. Lung. Dis. 2009, v. 13, p. 936-944.
  11. Maturu V.N., Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: Systematic review and meta-analysis. Clin. Exp. Allergy. 2015, v. 45, p. 1765-1778.
  12. Agarwal R.A., Chakrabarti A., Shah D. et al. For the ABPA complicating asthma ISHAM working group 2013. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clinical & Experimental Allergy. 2013, v. 43, p. 850-873.
  13. Eickmeier O., Rieber N., Eckrich J. et al. Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. Curr. Pharm. Des. 2013, v. 19, p. 3669-3678.
  14. Beauvais A., Fontaine T., Aimanianda V. Aspergillus cell wall and biofilm. Mycopathologia. 2014, v. 178, p. 371-377.
  15. Gresnigt M.S., Netea M.G., van de Veerdonk F.L. Pattern recognition receptors and their role in invasive aspergillosis. Ann. N.Y Acad. Sci. 2012, v. 1273, p. 60-67.
  16. Chai L.Y., van de Veerdonk F., Marijnissen R.J. et al. Anti-Aspergillus human host defence relies on type 1 T-helper (Th1), rather than type 17 T-helper (Th17), cellular immunity. Immunology. 2010, v. 130, p. 46-54.
  17. Bouzani M., Ok M., McCormick A. et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J. Immunol. 2011, v. 187, p. 1369-1376.
  18. Jolink H., Meijssen I.C., Hagedoorn R.S. et al. Characterization of the T-cell mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals. J. Infect. Dis. 2013, v. 208, p. 847-856.

Copyright (c) 2016 Pharmarus Print Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies